大剂量阿糖胞苷与米托蒽醌治疗高危急性非淋巴细胞白血病 - Suppr | 超能文献

High-dose cytosine arabinoside and mitoxantrone in high-risk acute nonlymphoblastic leukemia.

作者信息

Sanz M A, Martínez J, Borrego D, Martín-Aragonés G, Lorenzo I, Sanz G, Sayas M J, Jarque I, Pastor E, Rafecas J

出版信息

Semin Oncol. 1987 Jun;14(2 Suppl 1):18-20.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

High-dose cytosine arabinoside and mitoxantrone in high-risk acute nonlymphoblastic leukemia.大剂量阿糖胞苷与米托蒽醌治疗高危急性非淋巴细胞白血病

Semin Oncol. 1987 Jun;14(2 Suppl 1):18-20.

2

Treatment of acute myeloid leukemia with intermediate-dose cytosine arabinoside and mitoxantrone.用中剂量阿糖胞苷和米托蒽醌治疗急性髓系白血病。

Semin Oncol. 1987 Jun;14(2 Suppl 1):51-2.

3

Sequential flavopiridol, mitoxantrone and cytosine arabinoside for newly diagnosed poor risk acute myeloid leukemia. What to do next?序贯使用氟吡汀、米托蒽醌和阿糖胞苷治疗新诊断的高危急性髓系白血病。接下来该怎么做？

Leuk Res. 2010 Jul;34(7):856-7. doi: 10.1016/j.leukres.2010.03.008. Epub 2010 Apr 7.

4

[Mitoxantrone and conventional-dose cytosine arabinoside for relapsed and refractory acute leukemia].

Gan To Kagaku Ryoho. 1992 May;19(5):653-7.

5

Mitoxantrone.米托蒽醌

Med Lett Drugs Ther. 1988 Jul 1;30(769):67-8.

6

Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report.米托蒽醌与阿糖胞苷治疗成人急性白血病：中期报告

J Chemother. 1989 Jul;1(4 Suppl):1268-70.

7

Mitoxantrone and standard dose cytosine arabinoside therapy in refractory or relapsed acute leukemia.米托蒽醌与标准剂量阿糖胞苷治疗难治性或复发性急性白血病。

Acta Haematol. 1994;92(1):14-7. doi: 10.1159/000204130.

8

Fulminant hepatic failure after high-dose cytosine arabinoside and mitoxantrone treatment for relapse of acute myelogenous leukaemia.高剂量阿糖胞苷和米托蒽醌治疗急性髓性白血病复发后出现暴发性肝衰竭。

Eur J Haematol. 1992 Oct;49(4):221-3. doi: 10.1111/j.1600-0609.1992.tb00052.x.

9

[Intermediate-dose cytosine arabinoside in combination with mitoxantrone in the treatment of refractory leukemia].

Rinsho Ketsueki. 1988 Jul;29(7):1050-4.

10

High-dose cytosine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemia.大剂量阿糖胞苷联合米托蒽醌治疗难治性急性髓系白血病和急性淋巴细胞白血病

Semin Oncol. 1987 Jun;14(2 Suppl 1):73-7.

引用本文的文献

1

High-dose ara-C and etoposide in refractory or relapsing acute leukemia.大剂量阿糖胞苷和依托泊苷用于难治性或复发性急性白血病

Cancer Chemother Pharmacol. 1991;28(6):487-90. doi: 10.1007/BF00685829.

2

Five-day 4'-(9-acridinylamino)methanesulphon-m-anisidide and intermediate-dose cytosine arabinoside in high-risk relapsing or refractory acute myeloid leukemia.高危复发或难治性急性髓系白血病中五天4'-（9-吖啶基氨基）甲磺酰间甲氧基苯胺与中剂量阿糖胞苷联合治疗

J Cancer Res Clin Oncol. 1991;117(5):489-92. doi: 10.1007/BF01612772.

3

Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.米托蒽醌。对其药效学和药代动力学特性以及在癌症化疗中的治疗潜力的综述。

Drugs. 1991 Mar;41(3):400-49. doi: 10.2165/00003495-199141030-00007.